Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases
Recruiting
N/A
Interventional Study
Inflammatory Bowel Disease
Crohn's Disease (CD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 800 (estimated)
- Sponsor
- The Second Hospital of Nanjing Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body's metabolism. Evidence from animal and human studies strongly supports the link between intestinal bacteria and inflammatory bowel diseases (IBD). Dozens of studies reported its efficacy in treatment of severe Clostridium difficile colitis. Preliminary studies using fecal …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of Crohn's disease, with the diagnosis remaining unchanged after at least three months of follow-up.
Willingness to undergo FMT (Fecal Microbiota Transplantation).
Exclusion Criteria:
Presence of serious conditions that made them unsuitable for inclusion (e…
Contacts